- Home
- ASPI vs BDN Comparison
ASPI vs BDN Comparison
Compare ASPI & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- BDN
- Stock Information
- Founded
- ASPI 2021
- BDN 1986
- Country
- ASPI United States
- BDN United States
- Employees
- ASPI N/A
- BDN N/A
- Industry
- ASPI Major Chemicals
- BDN Real Estate Investment Trusts
- Sector
- ASPI Industrials
- BDN Real Estate
- Exchange
- ASPI Nasdaq
- BDN Nasdaq
- Market Cap
- ASPI 653.4M
- BDN 693.1M
- IPO Year
- ASPI 2022
- BDN N/A
- Fundamental
- Price
- ASPI $8.85
- BDN $3.95
- Analyst Decision
- ASPI Strong Buy
- BDN Hold
- Analyst Count
- ASPI 1
- BDN 2
- Target Price
- ASPI $11.00
- BDN $4.50
- AVG Volume (30 Days)
- ASPI 5.4M
- BDN 2.3M
- Earning Date
- ASPI 11-18-2025
- BDN 10-22-2025
- Dividend Yield
- ASPI N/A
- BDN 15.11%
- EPS Growth
- ASPI N/A
- BDN N/A
- EPS
- ASPI N/A
- BDN N/A
- Revenue
- ASPI $4,581,523.00
- BDN $306,596,000.00
- Revenue This Year
- ASPI $435.73
- BDN $55.21
- Revenue Next Year
- ASPI $221.50
- BDN $3.34
- P/E Ratio
- ASPI N/A
- BDN N/A
- Revenue Growth
- ASPI 99.57
- BDN N/A
- 52 Week Low
- ASPI $2.78
- BDN $3.41
- 52 Week High
- ASPI $11.86
- BDN $6.54
- Technical
- Relative Strength Index (RSI)
- ASPI 44.81
- BDN 31.88
- Support Level
- ASPI $8.78
- BDN $4.37
- Resistance Level
- ASPI $9.83
- BDN $4.20
- Average True Range (ATR)
- ASPI 0.83
- BDN 0.12
- MACD
- ASPI -0.15
- BDN -0.06
- Stochastic Oscillator
- ASPI 7.88
- BDN 0.00
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.